Inactive Instrument
Genex Pharmaceutical, Inc. Stock Other OTC
Stocks
GENX
US37227T1051
Medical Equipment, Supplies & Distribution
OTC Markets Traded
| Market Cap | 268K 233K 216K 202K 380K 25.26M 382K 2.56M 994K 12.43M 1M 983K 43.17M | P/E 2006 |
3.75x | P/E 2007 | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 413K 360K 333K 312K 585K 38.93M 588K 3.95M 1.53M 19.16M 1.55M 1.52M 66.53M | EV / Sales 2006 |
0.95x | EV / Sales 2007 | 1.6x |
| Free-Float |
99.62% | Yield 2006 * |
-
| Yield 2007 | - |
| 1 day | -4.55% |
| Manager | Title | Age | Since |
|---|---|---|---|
Fuzhi Song
CEO | Chief Executive Officer | 72 | - |
Shuli Zhang
DFI | Director of Finance/CFO | 72 | 2010-02-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Fuzhi Song
CHM | Chairman | 72 | 2010-02-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.55% | -39.83% | - | - | 1.78K | |
| +2.21% | -1.41% | -17.54% | +4.57% | 118B | |
| -0.66% | -0.71% | +4.75% | -9.49% | 12.63B | |
| +2.57% | +3.05% | +27.69% | +92.97% | 7.67B | |
| +0.48% | -3.09% | -46.17% | -71.45% | 4.07B | |
| +1.51% | +0.28% | +19.85% | +35.05% | 2.55B | |
| +0.94% | -1.24% | -13.34% | -15.72% | 1.77B | |
| -0.21% | -4.06% | +3.70% | -20.10% | 1.59B | |
| +5.36% | +9.88% | +200.71% | +151.86% | 1.49B | |
| Average | +0.85% | +0.99% | +22.46% | +20.96% | 18.72B | |
| Weighted average by Cap. | +1.92% | +0.74% | -11.04% | +7.33% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 2.44M 2.13M 1.97M 1.84M 3.46M 230M 3.48M 23.36M 9.05M 113M 9.15M 8.96M 393M | 3.24M 2.82M 2.61M 2.45M 4.59M 305M 4.62M 31.01M 12.02M 150M 12.15M 11.89M 522M |
| Net income | 619K 540K 500K 468K 878K 58.4M 883K 5.93M 2.3M 28.75M 2.32M 2.27M 99.82M | 343K 299K 277K 259K 486K 32.32M 489K 3.28M 1.27M 15.91M 1.29M 1.26M 55.24M |
| Net Debt | -0.19 -0.17 -0.16 -0.15 -0.27 -18.14 -0.27 -1.84 -0.71 -8.93 -0.72 -0.71 -31 | 0.14 0.13 0.12 0.11 0.21 13.67 0.21 1.39 0.54 6.73 0.54 0.53 23.36 |
Employees
-
